Spindle-Cell Variants of Primary Cutaneous Follicle Center B-Cell Lymphomas Are Germinal Center B-Cell Lymphomas by Gene Expression Profiling Using a Formalin-Fixed Paraffin-Embedded Specimen.

[1]  C. Magro,et al.  Primary cutaneous spindle cell B cell lymphoma: A report of three cases and review of the literature. , 2017, Annals of diagnostic pathology.

[2]  Rainer Spang,et al.  Reference point insensitive molecular data analysis , 2017, Bioinform..

[3]  D. Cappellen,et al.  MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma. , 2016, The Journal of investigative dermatology.

[4]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[5]  L. Cerroni,et al.  Cutaneous Spindle-Cell B-Cell Lymphomas: Most are Neoplasms of Follicular Center Cell Origin , 2015, The American journal of surgical pathology.

[6]  T. Petrella,et al.  High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type. , 2014, JAMA dermatology.

[7]  T. Petrella,et al.  Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma , 2014, Modern Pathology.

[8]  R. Spang,et al.  Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens. , 2013, Blood.

[9]  A. Rosenwald,et al.  Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. , 2011, Blood.

[10]  Remco Dijkman,et al.  Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. , 2005, Blood.

[11]  R. Siebert,et al.  Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. , 2004, The Journal of investigative dermatology.

[12]  R. Gascoyne,et al.  Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. , 2015, Blood.

[13]  C. Schmidt,et al.  Nuclear factor-κB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type. , 2014, The Journal of investigative dermatology.

[14]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.